Humanigen Inc (HGENQ)

[cowtown jay]

Former Board member Kevin Xie will be on familiar stomping grounds on behalf of Gracell and their, "potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost, and lack of effective CAR-T therapies for solid tumors and autoimmune diseases."

https://www.globenewswire.com/news-release/2023/09/14/2743346/0/en/Gracell-Biotechnologies-to-Participate-in-Three-Upcoming-Investor-Conferences.html

I wonder if our 10-Q and news will dim Gracell's spotlight, or if lenz have a role in their news.